As an investor, the most important things to watch are how fast their new capacity gets utilised, whether their top customers share of revenue starts to reduce (lowering concentration risk), and whether management keeps delivering on promises post-IPO
Also a great price for those not using insurance
PubMed, Martnez, Mara Elena, et al
As a class effect shared with GLP-1 receptor agonists, there is a precautionary concern regarding thyroid C-cell tumours, based on animal studies
Quick Answer: A GLP-1 journey is the comprehensive treatment experience with glucagon-like peptide-1 receptor agonist medications, involving gradual dose escalation, ongoing monitoring, and typically long-term therapy for type 2 diabetes or chronic weight management